Med-Tech Innovation August 5, 2024
Indica Labs, a leading provider of AI-powered digital pathology solutions, has announced the launch of Lung Macrodissect AI, a tool that the company says ‘revolutionises’ slide macrodissection and molecular pathology workflows.
The company says Lung Macrodissect AI represents a significant leap forward for the integration of artificial intelligence with digital pathology by offering pathologists a streamlined macrodissection workflow that minimises human error and improves efficiency.
Lung Macrodissect AI is deployed in HALO AP, quantifies tumour content, streamlines tumour annotation, and ensures specimen quality for downstream analysis according to Indica.
Tumour content estimation and macrodissection are critical steps in molecular pathology, involving the assessment of tumour content within a sample and the precise isolation and removal of tumour regions for downstream...
Today's Sponsors
Today's Sponsor